Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 190

1.

High expression of phosphorylated 4E-binding protein 1 is an adverse prognostic factor in esophageal squamous cell carcinoma.

Yeh CJ, Chuang WY, Chao YK, Liu YH, Chang YS, Kuo SY, Tseng CK, Chang HK, Hsueh C.

Virchows Arch. 2011 Feb;458(2):171-8. doi: 10.1007/s00428-010-0994-5. Epub 2010 Nov 3.

PMID:
21046149
2.

High phosphorylated 4E-binding protein 1 expression after chemoradiotherapy is a predictor for locoregional recurrence and worse survival in esophageal squamous cell carcinoma patients.

Chao YK, Chuang WY, Yeh CJ, Chang YS, Wu YC, Kuo SY, Hsieh MJ, Hsueh C.

J Surg Oncol. 2012 Mar;105(3):288-92. doi: 10.1002/jso.22097. Epub 2011 Sep 19.

PMID:
21932407
3.

Cell signaling in endometrial carcinoma: phosphorylated 4E-binding protein-1 expression in endometrial cancer correlates with aggressive tumors and prognosis.

Castellvi J, Garcia A, Ruiz-Marcellan C, Hernández-Losa J, Peg V, Salcedo M, Gil-Moreno A, Ramon y Cajal S.

Hum Pathol. 2009 Oct;40(10):1418-26. doi: 10.1016/j.humpath.2008.12.019. Epub 2009 May 9.

PMID:
19428047
4.

Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.

Ren HZ, Pan GQ, Wang JS, Wen JF, Wang KS, Luo GQ, Shan XZ.

Dig Dis Sci. 2010 Sep;55(9):2552-60. doi: 10.1007/s10620-009-1065-0. Epub 2010 Jan 27.

PMID:
20108042
5.

Phosphorylated 4E-binding protein 1 (p-4E-BP1): a novel prognostic marker in human astrocytomas.

Korkolopoulou P, Levidou G, El-Habr EA, Piperi C, Adamopoulos C, Samaras V, Boviatsis E, Thymara I, Trigka EA, Sakellariou S, Kavantzas N, Patsouris E, Saetta AA.

Histopathology. 2012 Aug;61(2):293-305. doi: 10.1111/j.1365-2559.2012.04236.x. Epub 2012 Jun 13.

PMID:
22690797
6.

Tyrosine-protein phosphatase nonreceptor type 12 is a novel prognostic biomarker for esophageal squamous cell carcinoma.

Cao X, Li Y, Luo RZ, He LR, Yang J, Zeng MS, Wen ZS.

Ann Thorac Surg. 2012 May;93(5):1674-80. doi: 10.1016/j.athoracsur.2011.12.056. Epub 2012 Mar 17.

PMID:
22429674
7.

Prognostic relevance of Id-1 expression in patients with resectable esophageal squamous cell carcinoma.

Luo KJ, Wen J, Xie X, Fu JH, Luo RZ, Wu QL, Hu Y.

Ann Thorac Surg. 2012 May;93(5):1682-8. doi: 10.1016/j.athoracsur.2012.01.102. Epub 2012 Apr 4.

PMID:
22480390
8.

Significance of macrophage chemoattractant protein-1 expression and macrophage infiltration in squamous cell carcinoma of the esophagus.

Koide N, Nishio A, Sato T, Sugiyama A, Miyagawa S.

Am J Gastroenterol. 2004 Sep;99(9):1667-74.

PMID:
15330899
9.

Phosphorylated mammalian target of rapamycin expression is associated with the response to chemoradiotherapy in patients with esophageal squamous cell carcinoma.

Li SH, Huang EY, Lu HI, Huang WT, Yen CC, Huang WC, Chen CH.

J Thorac Cardiovasc Surg. 2012 Dec;144(6):1352-9, 1359.e1. doi: 10.1016/j.jtcvs.2012.06.049. Epub 2012 Jul 25.

10.

Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.

Kato H, Yoshikawa M, Miyazaki T, Nakajima M, Fukai Y, Masuda N, Fukuchi M, Manda R, Tsukada K, Kuwano H.

Anticancer Res. 2002 Nov-Dec;22(6C):3977-84.

PMID:
12553021
11.

Phosphorylated 4E binding protein 1: a hallmark of cell signaling that correlates with survival in ovarian cancer.

Castellvi J, Garcia A, Rojo F, Ruiz-Marcellan C, Gil A, Baselga J, Ramon y Cajal S.

Cancer. 2006 Oct 15;107(8):1801-11.

12.

Prognostic significance and function of phosphorylated ribosomal protein S6 in esophageal squamous cell carcinoma.

Kim SH, Jang YH, Chau GC, Pyo S, Um SH.

Mod Pathol. 2013 Mar;26(3):327-35. doi: 10.1038/modpathol.2012.161. Epub 2012 Sep 21.

13.

Phosphorylated p70S6K expression is an independent prognosticator for patients with esophageal squamous cell carcinoma.

Li SH, Chen CH, Lu HI, Huang WT, Tien WY, Lan YC, Lee CC, Chen YH, Huang HY, Chang AY, Lin WC.

Surgery. 2015 Mar;157(3):570-80. doi: 10.1016/j.surg.2014.10.014. Epub 2014 Nov 6.

PMID:
25726316
14.

Prognostic significance of biologic factors in squamous cell carcinoma of the esophagus.

Ikeda G, Isaji S, Chandra B, Watanabe M, Kawarada Y.

Cancer. 1999 Oct 15;86(8):1396-405.

PMID:
10526265
15.

Prognostic value of raf kinase inhibitor protein in esophageal squamous cell carcinoma.

Gao C, Pang L, Ren C, Ma T.

Pathol Oncol Res. 2012 Apr;18(2):471-7. doi: 10.1007/s12253-011-9470-z. Epub 2011 Nov 19.

PMID:
22102006
16.

Prognostic significance of global histone modifications in resected squamous cell carcinoma of the esophagus.

Tzao C, Tung HJ, Jin JS, Sun GH, Hsu HS, Chen BH, Yu CP, Lee SC.

Mod Pathol. 2009 Feb;22(2):252-60. doi: 10.1038/modpathol.2008.172. Epub 2008 Oct 24.

17.

Nuclear expression of phosphorylated EGFR is associated with poor prognosis of patients with esophageal squamous cell carcinoma.

Hoshino M, Fukui H, Ono Y, Sekikawa A, Ichikawa K, Tomita S, Imai Y, Imura J, Hiraishi H, Fujimori T.

Pathobiology. 2007;74(1):15-21.

PMID:
17496429
18.

Expression of the eukaryotic translation initiation factor 4E (eIF4E) and 4E-BP1 in esophageal cancer.

Salehi Z, Mashayekhi F.

Clin Biochem. 2006 Apr;39(4):404-9. Epub 2005 Dec 20.

PMID:
16375881
19.

Preoperative serum midkine concentration is a prognostic marker for esophageal squamous cell carcinoma.

Shimada H, Nabeya Y, Tagawa M, Okazumi S, Matsubara H, Kadomatsu K, Muramatsu T, Ikematsu S, Sakuma S, Ochiai T.

Cancer Sci. 2003 Jul;94(7):628-32.

20.

Molecular analysis of surgical margins in head and neck squamous cell carcinoma patients.

Nathan CO, Amirghahri N, Rice C, Abreo FW, Shi R, Stucker FJ.

Laryngoscope. 2002 Dec;112(12):2129-40.

PMID:
12461330

Supplemental Content

Support Center